Showa Shell Sekiyu K.K.:企業の戦略・SWOT・財務情報

◆英語タイトル:Showa Shell Sekiyu K.K. - Strategy, SWOT and Corporate Finance Report
◆商品コード:DATA904C8921
◆発行会社(調査会社):MarketLine
◆発行日:2018年10月
◆ページ数:46
◆レポート言語:英語
◆レポート形式:PDF
◆納品方法:Eメール
◆対象地域:日本
◆産業分野:化学
◆販売価格オプション(消費税別)
Single User(1名様閲覧用)USD175 ⇒換算¥25,900見積依頼/購入/質問フォーム
Site License(同一事業所内共有可)USD350 ⇒換算¥51,800見積依頼/購入/質問フォーム
Enterprisewide License(複数事業所内共有可)USD525 ⇒換算¥77,700見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日〜2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送しますので、請求書発行日より2ヶ月以内に振込をお願いします。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はMarketLine社の日本における正規販売代理店です。同社発行の企業調査レポートに関するお問い合わせは弊社までお願い致します。
MarketLine社の概要はこちらでご確認いただけます。



【レポートの概要】

Showa Shell Sekiyu K.K. – Strategy, SWOT and Corporate Finance Report
Summary

Showa Shell Sekiyu K.K. – Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company’s structure, operation, SWOT analysis, product and service offerings and corporate actions, providing a 360˚ view of the company.

Key Highlights

Showa Shell Sekiyu K. K. (Showa Shell or ‘the company’) a subsidiary of Royal Dutch Shell plc, engaged in crude oil procurement, refining and sale of refined oil products. The company also offers energy solutions such as solar and electric solutions. Showa Shell’s key products include gasoline, diesel, kerosene, automotive lubricants, greases, bitumen, naphtha, solar panels and systems, thin-film solar module, butane, xylene, benzene, propylene, and heating oil. The company has its operations across the Europe, the U.S., the Middle East, and Asia, including Japan. Showa Shell is headquartered in Minato-ku, Tokyo, Japan.

Scope

- Detailed information on Showa Shell Sekiyu K.K. required for business and competitor intelligence needs
- A study of the major internal and external factors affecting Showa Shell Sekiyu K.K. in the form of a SWOT analysis
- An in-depth view of the business model of Showa Shell Sekiyu K.K. including a breakdown and examination of key business segments
- Intelligence on Showa Shell Sekiyu K.K.’s mergers and acquisitions (MandA), strategic partnerships and alliances, capital raising, private equity transactions, and financial and legal advisors
- News about Showa Shell Sekiyu K.K., such as business expansion, restructuring, and contract wins
- Large number of easy-to-grasp charts and graphs that present important data and key trends

Reasons to buy

- Gain understanding of Showa Shell Sekiyu K.K. and the factors that influence its strategies.
- Track strategic initiatives of the company and latest corporate news and actions.
- Assess Showa Shell Sekiyu K.K. as a prospective partner, vendor or supplier.
- Support sales activities by understanding your customers’ businesses better.
- Stay up to date on Showa Shell Sekiyu K.K.’s business structure, strategy and prospects.

【レポートの目次】

Table of Contents
Company Snapshot 2
Table of Contents 5
Showa Shell Sekiyu K.K.: Company Overview 9
Showa Shell Sekiyu K.K.: Overview and Key Facts 9
Showa Shell Sekiyu K.K.: Overview 9
Showa Shell Sekiyu K.K.: Key Facts 9
Showa Shell Sekiyu K.K.: Key Employees 11
Showa Shell Sekiyu K.K.: Key Employee Biographies 13
Showa Shell Sekiyu K.K.: Major Products and Services 14
Showa Shell Sekiyu K.K.: Company History 15
Showa Shell Sekiyu K.K.: Management Statement 23
Showa Shell Sekiyu K.K.: Locations and Subsidiaries 25
Showa Shell Sekiyu K.K.: Key Competitors 26
Showa Shell Sekiyu K.K.: Company Analysis 27
Showa Shell Sekiyu K.K.: Business Description 27
Showa Shell Sekiyu K.K.: SWOT Analysis 28
Showa Shell Sekiyu K.K.: SWOT Overview 28
Showa Shell Sekiyu K.K.: Strengths 28
Showa Shell Sekiyu K.K.: Weaknesses 29
Showa Shell Sekiyu K.K.: Opportunities 29
Showa Shell Sekiyu K.K.: Threats 30
Showa Shell Sekiyu K.K.: Corporate Financial Deals Activity 32
Showa Shell Sekiyu K.K.: Financial Deals Overview 32
Showa Shell Sekiyu K.K.: Top Deals 2014 – 2018YTD* 33
Showa Shell Sekiyu K.K.: Advisors 34
Showa Shell Sekiyu K.K.: Top Legal Advisors 34
Showa Shell Sekiyu K.K.: Top Financial Advisors 34
Showa Shell Sekiyu K.K.: Mergers and Acquisitions 35
Showa Shell Sekiyu K.K.: Recent Developments 36
Showa Shell Sekiyu K.K.: News and Events Summary 36
Showa Shell Sekiyu K.K.: Financial Deals 39
Showa Shell Sekiyu K.K.: Financial Performance 39
Showa Shell Sekiyu K.K.: Regulatory and Legal Events 41
Showa Shell Sekiyu K.K.: Strategy and Operations 42
Appendix 44
Contact Us 44
Methodology 44
About MarketLine 45

List of Tables
Table 1: Showa Shell Sekiyu K.K.: Key Facts
Table 2: Showa Shell Sekiyu K.K.: Key Employees
Table 3: Showa Shell Sekiyu K.K.: Company History
Table 4: Showa Shell Sekiyu K.K.: Locations and Subsidiaries
Table 5: Showa Shell Sekiyu K.K.: Key Competitors
Table 6: Showa Shell Sekiyu K.K.: Deal Activity by Deal Type - Volume (2014 - YTD*2018)
Table 7: Showa Shell Sekiyu K.K.: M&A Average Deal Size - Value (US$m)
Table 8: Showa Shell Sekiyu K.K.: Top Deals 2014 - 2018YTD*
Table 9: Showa Shell Sekiyu K.K.: Legal Advisor Ranking by Value (US$m)
Table 10: Showa Shell Sekiyu K.K.: Financial Advisor Ranking by Value (US$m)
Table 11: Showa Shell Sekiyu K.K.: M&A Volume and Value Trend (2014 - YTD*2018)
Table 12: Showa Shell Sekiyu K.K.: News and Events Summary
Table 13: Showa Shell Sekiyu K.K.: Financial Deals
Table 14: Showa Shell Sekiyu K.K.: Financial Performance
Table 15: Showa Shell Sekiyu K.K.: Regulatory and Legal Events
Table 16: Showa Shell Sekiyu K.K.: Strategy and Operations

List of Figures
Figure 1: Showa Shell Sekiyu K.K.: Deal Activity by Deal Type - Volume (2014 - YTD*2018)
Figure 2: Showa Shell Sekiyu K.K.: M&A Average Deal Size - Value (US$m)
Figure 3: Showa Shell Sekiyu K.K.: M&A Volume and Value Trend (2014 - YTD*2018)

★海外企業調査レポート[Showa Shell Sekiyu K.K.:企業の戦略・SWOT・財務情報]についてメールでお問い合わせはこちら

■おすすめ企業レポート■
  • XuanZhu Pharma Co Ltd-製薬・医療分野:企業M&A・提携分析
    Summary XuanZhu Pharma Co Ltd (XuanZhu), a subsidiary of Sihuan Pharmaceutical Holdings Group Ltd is a healthcare company that research, develops, manufactures and sales drugs. The company’s products include anti-infective drugs apapenem and benapenem; anti-acid drug anaprazole sodium, anti-diabetic …
  • Sunoco LP (SUN):石油・ガス:M&Aディール及び事業提携情報
    Summary Sunoco LP (Sunoco), a master limited partnership company that sells motor fuels in retail and wholesale channels. It offers motor fuel under brands such as Sunoco, Citgo, Chevron, Conoco, Aloha, Exxon, Mahalo, Mobil, Phillips 66, Texaco, Shell, Shamrock and Valero. The company operates throu …
  • Lotte Chemical Corp (011170):企業の財務・戦略的SWOT分析
    Lotte Chemical Corp (011170) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknes …
  • SDN Company Ltd (099220):電力:M&Aディール及び事業提携情報
    Summary SDN Company Ltd (SDN Company), formerly Seoul Marine Co Ltd is a diversified company that operates through its business divisions such as photovoltaic, engine, and shipbuilding divisions. The company’s photovoltaic business division manufactures solar inverters, solar panels, solar trackers, …
  • OJSC Rosneft Oil Company:企業の戦略・SWOT・財務情報
    OJSC Rosneft Oil Company - Strategy, SWOT and Corporate Finance Report Summary OJSC Rosneft Oil Company - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service o …
  • Alimera Sciences Inc (ALIM):製薬・医療:M&Aディール及び事業提携情報
    Summary Alimera Sciences Inc (Alimera) is a biopharmaceutical company that researches, develops and commercializes prescription ophthalmic pharmaceuticals. The company’s products include Iluvien, an intravitreal implant of fluocinolone acetonide which is indicated for the treatment of chronic diabet …
  • BerGenBio ASA (BGBIO)-製薬・医療分野:企業M&A・提携分析
    Summary BerGenBio ASA (BerGenBio) is a developer of drugs for aggressive and drug resistant cancers. The company develops epithelial-mesenchymal transition inhibitors for acquired cancer drug-resistance and metastasis. Its BGB324 finds application in the treatment of drug resistant chronic myeloid l …
  • Dr. Reddy’s Research and Development BV-医療機器分野:企業M&A・提携分析
    Summary Dr. Reddy’s Research and Development BV (Dr. Reddy’s Research and Development), a subsidiary of Dr. Reddy's Laboratories Ltd is a drug formulation and manufacturing service provider that develops and manufactures improved injectable pharmaceuticals. The company offers services such as formul …
  • Nigerian National Petroleum Corp:石油・ガス:M&Aディール及び事業提携情報
    Summary Nigerian National Petroleum Corp (NNPC) is a state-owned vertically integrated oil and gas company, which explores for, produces, markets and distributes crude oil, refined petroleum, petrochemicals and associated by-products. It operates through a network of refineries that produce products …
  • Reliance Communications Ltd (RCOM):企業の財務・戦略的SWOT分析
    Reliance Communications Ltd (RCOM) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and w …
  • Senju Pharmaceutical Co Ltd:企業の戦略的SWOT分析
    Senju Pharmaceutical Co Ltd - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major product …
  • International Stem Cell Corp (ISCO):企業の財務・戦略的SWOT分析
    Summary International Stem Cell Corp (ISCC) is a clinical stage biotechnology company that develops stem cell technology solutions. The company develops parthenogenesis, a stem cell technology that improves the field of regenerative medicine. It provides stem cells such as embryonic stem cells, adul …
  • Enyo Pharma SA:製薬・医療:M&Aディール及び事業提携情報
    Summary Enyo Pharma SA (Enyo Pharma) is a biopharmaceutical company that develops molecules modulating host functions for the treatment of acute and chronic viral infections. The company provides technology which develops tools combining biological experimentation and computational development to id …
  • Bank Sepah:企業の戦略・SWOT・財務情報
    Bank Sepah - Strategy, SWOT and Corporate Finance Report Summary Bank Sepah - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corporate actio …
  • Nightstar Therapeutics PLC (NITE):製薬・医療:M&Aディール及び事業提携情報
    Summary Nightstar Therapeutics PLC (Nightstar Therapeutics), formerly Nightstar Therapeutics Ltd, is a clinical-stage gene therapy company. The company focus on developing and commercializing novel one-time treatments for patients suffering from rare inherited retinal diseases. Its lead product cand …
  • Arup Group Ltd:企業の戦略的SWOT分析
    Arup Group Ltd - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products and service …
  • WPG Holdings Limited:企業の戦略・SWOT・財務情報
    WPG Holdings Limited - Strategy, SWOT and Corporate Finance Report Summary WPG Holdings Limited - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings …
  • Univalor-製薬・医療分野:企業M&A・提携分析
    Summary Univalor is a university technology transfer organization which optimizes research outcomes by commercializing the technological innovations of researchers from academic institutions and health centers. The organization offers researcher services such as evaluating the technical feasibility …
  • FANCL Corporation:企業の戦略・SWOT・財務情報
    FANCL Corporation - Strategy, SWOT and Corporate Finance Report Summary FANCL Corporation - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and c …
  • Industrija nafte dd (INA-R-A):石油・ガス:M&Aディール及び事業提携情報
    Summary Industrija nafte dd (INA) is an integrated energy company, which operates across the energy value chain from exploration and production to refining and marketing to retail. It has interests in offshore and onshore assets in Croatia, Egypt, and Angola. The company manages refineries in Rijeka …

◆H&Iグローバルリサーチ株式会社のお客様(例)◆